Deep brain stimulation (DBS) has considerable efficacy for the motor dysfunction of idiopathic Parkinson’s disease (PD) on patient quality of life. However, the benefit of DBS on voice and speech quality remains controversial. We carried out a systematic review to understand the influence of DBS on parkinsonian dysphonia and dysarthria.
Data Sources
A PubMed/MEDLINE and Cochrane systematic review was carried out following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Population, Intervention, Comparison, Outcome, Timing, and Setting (PICOTS) statements.
Review Methods
Three investigators screened studies published in the literature from inception to May 2022. The following data were retrieved: age, demographic, sex, disease duration, DBS duration, DBS location, speech, and voice quality measurements.
Results
From the 180 studies identified, 44 publications met the inclusion criteria, accounting for 866 patients. Twenty-nine studies focused on voice/speech quality in subthalamic DBS patients, and 6 included patients with stimulation of pallidal, thalamic, and zona incerta regions. Most studies (4/6) reported a deterioration of the vocal parameters on subjective voice quality evaluation. For speech, the findings were more contrasted. There was an important heterogeneity between studies regarding the voice and speech quality outcomes used to evaluate the impact of DBS on voice/speech quality.
Conclusion
The impact of DBS on voice and speech quality significantly varies between studies. The stimulated anatomical region may have a significant role since the stimulation of the pallidal area was mainly associated with voice quality improvement, in contrast with other regions. Future controlled studies comparing all region stimulation are needed to get reliable findings.
Level of Evidence
Level III: evidence from evidence summaries developed from systematic reviews
IranzoA. REM sleep behavior disorder, a parasomnia that predicts Parkinson disease and dementia with Lewy bodies. Eur Neuropsychopharmacol. 2021;46:52-53.
4.
MidiIDoganMKoseogluMCanGSehitogluMAGunalDI. Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurol Scand. 2008;117(1):26-34.
5.
HoAKIansekRMariglianiCBradshawJLGatesS. Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol. 1999;11(3):131-137.
6.
LechienJRBlecicSHuetK, et al. Voice quality outcomes of idiopathic Parkinson’s disease medical treatment: a systematic review. Clin Otolaryngol. 2018;43(3):882-903.
7.
PintoSGhioATestonBVialletF. Dysarthria across Parkinson’s disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria [in French]. Rev Neurol (Paris). 2010;166(10):800-810.
8.
BenabidALChabardesSMitrofanisJPollakP. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol. 2009;8(1):67-81.
9.
ChikenSNambuA. Mechanism of deep brain stimulation. Neuroscientist. 2016;22(3):313-322.
10.
Wyman-ChickKA. Verbal fluency in Parkinson’s patients with and without bilateral deep brain stimulation of the subthalamic nucleus: a meta-analysis. J Int Neuropsychol Soc. 2016;22(4):478-485.
11.
ThompsonMTiwariAFuRMoeEBuckleyDI. A Framework to Facilitate the Use of Systematic Reviews and Meta-Analyses in the Design of Primary Research Studies. Agency for Healthcare Research and Quality; 2012. Accessed December 27, 2021. http://www.ncbi.nlm.nih.gov/books/NBK83621/
12.
McInnesMDFMoherDThombsBD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388-396.
13.
SackettDL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. CHEST. 1989;95(2):2S-4S.
14.
BurnsPBRohrichRJChungKC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305-310.
15.
ViswanathanMBerkmanNDDrydenDMHartlingL. Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank. Agency for Healthcare Research and Quality; 2013. Accessed November 9, 2021. https://www.ncbi.nlm.nih.gov/books/NBK154463/
16.
TanakaYTsuboiTWatanabeH, et al. Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Neurol. 2015;262(5):1173-1181.
17.
TsuboiTWatanabeHTanakaY, et al. Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder. J Neural Transm (Vienna). 2015;122(12):1663-1672.
18.
D’AlatriLPaludettiGContarinoMFGallaSMarcheseMRBentivoglioAR. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice. 2008;22(3):365-372.
19.
KlostermannFEhlenFVesperJ, et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79(5):522-529.
20.
TörnqvistALSchalénLRehncronaS. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Mov Disord. 2005;20(4):416-423.
21.
TripolitiEStrongLHickeyF, et al. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson’s disease. Mov Disord. 2011;26(13):2434-2436.
22.
SpielmanJMahlerLHalpernAGilleyPKlepitskayaORamigL. Intensive voice treatment (LSVT®LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. J Commun Disord. 2011;44(6):688-700.
23.
FabbriMZibettiMFerreroG, et al. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson’s disease patients with dysarthria?Parkinsonism Relat Disord. 2019;64:242-248.
24.
MorelloANDCBeberBCFagundesVCCieloCARiederCRM. Dysphonia and dysarthria in people with Parkinson’s disease after subthalamic nucleus deep brain stimulation: effect of frequency modulation. J Voice. 2020;34(3):477-484.
25.
DayalVGroverTTripolitiE, et al. Short versus conventional pulse-width deep brain stimulation in Parkinson’s disease: a randomized crossover comparison. Mov Disord. 2020;35(1):101-108.
26.
ZhangSZhouPJiangSWangWLiP. Interleaving subthalamic nucleus deep brain stimulation to avoid side effects while achieving satisfactory motor benefits in Parkinson disease: a report of 12 cases. Medicine (Baltimore). 2016;95(49):e5575.
27.
Piña-FuentesDvan DijkJMCvan ZijlJC, et al. Acute effects of adaptive deep brain stimulation in Parkinson’s disease. Brain Stimul. 2020;13(6):1507-1516.
28.
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738-750.
29.
MyrbergKHydénLCSamuelssonC. The Mini-Mental State Examination (MMSE) from a language perspective: an analysis of test interaction. Clin Linguist Phon. 2020;34(7):652-670.
30.
CooperSEMcIntyreCCFernandezHHVitekJL. Association of deep brain stimulation washout effects with Parkinson disease duration. JAMA Neurol. 2013;70(1):95-99.
31.
TsuboiTWatanabeHTanakaY, et al. Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. 2015;86(8):856-864.
32.
SkoddaS. Effect of deep brain stimulation on speech performance in Parkinson’s disease. Parkinsons Dis. 2012;2012:850596.
33.
LuGLuoLLiuM, et al. Outcomes and adverse effects of deep brain stimulation on the ventral intermediate nucleus in patients with essential tremor. Neural Plast. 2020;2020:2486065.
34.
DietzJNoeckerAMMcIntyreCC, et al. Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul. 2013;6(3):248-253.
35.
AuKLKWongJKTsuboiT, et al. Globus pallidus internus (GPi) deep brain stimulation for Parkinson’s disease: expert review and commentary. Neurol Ther. 2021;10(1):7-30.
36.
DashtipourKTafreshiALeeJCrawleyB. Speech disorders in Parkinson’s disease: pathophysiology, medical management and surgical approaches. Neurodegener Dis Manag. 2018;8(5):337-348.
37.
BrabenecLMekyskaJGalazZRektorovaI. Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm (Vienna). 2017;124(3):303-334.
38.
VonbergIEhlenFFrommOKühnAAKlostermannF. Deep brain stimulation of the subthalamic nucleus improves lexical switching in Parkinson’s disease patients. PLoS One. 2016;11(8):e0161404.
39.
TanakaYTsuboiTWatanabeH, et al. Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinson’s disease patients: a 2-year prospective study. J Parkinsons Dis. 2020;10(1):131-140.
40.
TsuboiTWatanabeHTanakaY, et al. Early detection of speech and voice disorders in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study. J Neural Transm (Vienna). 2017;124(12):1547-1556.
41.
LechienJRDelsautBAbderrakibA, et al. Orofacial strength and voice quality as outcome of levodopa challenge test in Parkinson disease. Laryngoscope. 2020;130(12):E896-E903.
42.
MillerN. Speech, voice and language in Parkinson’s disease: changes and interventions. Neurodegenerative Dis Manage. 2012;2(3):279-289.
43.
JankovicJ. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-376.
44.
LechienJRHuetKFinckC, et al. Are the acoustic measurements reliable in the assessment of voice quality? A methodological prospective study. J Voice. 2021;35(2):203-215.
45.
FenoyAJMcHenryMASchiessMC. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract. J Neurosurg. 2017;126(6):2017-2027.
46.
EhlenFSchoeneckerTKühnAAKlostermannF. Differential effects of deep brain stimulation on verbal fluency. Brain Lang. 2014;134:23-33.
47.
BatensKDe LetterMRaedtR, et al. Subthalamic nucleus stimulation and spontaneous language production in Parkinson’s disease: a double laterality problem. Brain Lang. 2015;147:76-84.
48.
AnzakAGaynorLBeigiM, et al. A gamma band specific role of the subthalamic nucleus in switching during verbal fluency tasks in Parkinson’s disease. Exp Neurol. 2011;232(2):136-142.
49.
EhlenFKrugelLKVonbergISchoeneckerTKühnAAKlostermannF. Intact lexicon running slowly—prolonged response latencies in patients with subthalamic DBS and verbal fluency deficits. PLoS One. 2013;8(11):e79247.
50.
KarlJAOuyangBVerhagen MetmanL. A novel dual-frequency deep brain stimulation paradigm for Parkinson’s disease. Neurol Ther. 2019;8(2):483-489.
51.
KeaneMDeyoSAboschABajwaJAJohnsonMD. Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng. 2012;9(4):046005.
52.
NguyenTAKDjilasMNowackiA, et al. Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus. PLoS One. 2019;14(6):e0217985.
53.
PourfarMHMogilnerAY. Lead angle matters: side effects of deep brain stimulation improved with adjustment of lead angle. Neuromodulation. 2016;19(8):877-881.
54.
PintoSFerrayeMEspesserR, et al. Stimulation of the pedunculopontine nucleus area in Parkinson’s disease: effects on speech and intelligibility. Brain. 2014;137(pt 10):2759-2772.
55.
VosSHKesselsRPCVinkeRSEsselinkRAJPiaiV. The effect of deep brain stimulation of the subthalamic nucleus on language function in Parkinson’s disease: a systematic review. J Speech Lang Hear Res. 2021;64(7):2794-2810.
56.
LeimbachFAtkinson-ClementCWilkinsonLCheungCJahanshahiM. Dissociable effects of subthalamic nucleus deep brain stimulation surgery and acute stimulation on verbal fluency in Parkinson’s disease. Behav Brain Res. 2020;388:112621.
57.
BehroozmandRJohariKKelleyRMKapnoulaECNarayananNSGreenleeJDW. Effect of deep brain stimulation on vocal motor control mechanisms in Parkinson’s disease. Parkinsonism Relat Disord. 2019;63:46-53.
58.
YilmazASaracETAydinliFEYildizgorenMTOkuyucuEESerarslanY. Investigating the effect of STN-DBS stimulation and different frequency settings on the acoustic-articulatory features of vowels. Neurol Sci. 2018;39(10):1683-1689.
59.
Martel-SauvageauVTjadenK. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson’s disease. J Commun Disord. 2017;70:1-11.
60.
RomannAJBeberBCOlchikMRRiederCRM. Different outcomes of phonemic verbal fluency in Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Arq Neuropsiquiatr. 2017;75(4):216-220.
61.
TanakaYTsuboiTWatanabeH, et al. Articulation features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Parkinsons Dis. 2016;6(4):811-819.
62.
EklundEQvistJSandströmLViklundFVan DoornJKarlssonF. Perceived articulatory precision in patients with Parkinson’s disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta. Clin Linguist Phon. 2015;29(2):150-166.
63.
KrugelLKEhlenFTiedtHOKühnAAKlostermannF. Differential impact of thalamic versus subthalamic deep brain stimulation on lexical processing. Neuropsychologia. 2014;63:175-184.
64.
MarshallDFStruttAMWilliamsAESimpsonRKJankovicJYorkMK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. Eur J Neurol. 2012;19(12):1525-1531.
65.
SilveriMCCiccarelliNBaldoneroE, et al. Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson’s disease. Neuropsychologia. 2012;50(8):1980-1989.
66.
SchulzGMHoseyLABradberryTJ, et al. Selective left, right and bilateral stimulation of subthalamic nuclei in Parkinson’s disease: differential effects on motor, speech and language function. J Parkinsons Dis. 2012;2(1):29-40.
67.
XieYZhangYZhengZ, et al. Changes in speech characters of patients with Parkinson’s disease after bilateral subthalamic nucleus stimulation. J Voice. 2011;25(6):751-758.
68.
Van Lancker SidtisDRogersTGodierVTagliatiMSidtisJJ. Voice and fluency changes as a function of speech task and deep brain stimulation. J Speech Lang Hear Res. 2010;53(5):1167-1177.
69.
LeeVSZhouXPRahnDAWangEQJiangJJ. Perturbation and nonlinear dynamic analysis of acoustic phonatory signal in Parkinsonian patients receiving deep brain stimulation. J Commun Disord. 2008;41(6):485-500.
70.
DromeyCKumarRLangAELozanoAM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord. 2000;15(6):1132-1138.
71.
ChiuSYTsuboiTHeglandKW, et al. Dysarthria and speech intelligibility following Parkinson’s disease globus pallidus internus deep brain stimulation. J Parkinsons Dis. 2020;10(4):1493-1502.
72.
SandströmLHägglundPJohanssonLBlomstedtPKarlssonF. Speech intelligibility in Parkinson’s disease patients with zona incerta deep brain stimulation. Brain Behav. 2015;5(10):e00394.
73.
AströmMTripolitiEHarizMI, et al. Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation. Stereotact Funct Neurosurg. 2010;88(4):224-233.
74.
FabbriMNataleFArtusiCA, et al. Deep brain stimulation fine-tuning in Parkinson’s disease: short pulse width effect on speech. Parkinsonism Relat Disord. 2021;87:130-134.
75.
LittleSTripolitiEBeudelM, et al. Adaptive deep brain stimulation for Parkinson’s disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry. 2016;87(12):1388-1389.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
